Capillary leak syndrome: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 7: Line 7:
'''''Synonyms and Keywords:''''' Systemic capillary leak syndrome; SCLS; Clarkson's disease.
'''''Synonyms and Keywords:''''' Systemic capillary leak syndrome; SCLS; Clarkson's disease.


==Overview==


==Historical Perspective==
 
The [[syndrome]] was first described by B. Clarkson in 1960,<ref name="clarkson">{{cite journal |doi=10.1016/0002-9343(60)90018-8 |title=Cyclical edema and shock due to increased capillary permeability |year=1960 |last1=Clarkson |first1=Bayard |last2=Thompson |first2=David |last3=Horwith |first3=Melvin |last4=Luckey |first4=E.Hugh |journal=The American Journal of Medicine |volume=29 |issue=2 |pmid=13693909 |pages=193–216}}</ref> after whom it was later informally named. Beyond numerous case reports published since then, two comprehensive reviews of clinical and research experience were published in 2010.<ref name="druey">{{cite journal |first1=Kirk M. |last1=Druey |first2=Philip R. |last2=Greipp |title=Narrative Review: Clarkson Disease-Systemic Capillary Leak Syndrome |journal=Annals of Internal Medicine |pmid=20643990 |pages=90–8 |doi=10.1059/0003-4819-153-2-201007200-00005 |pmc=3017349 |year=2010 |volume=153 |issue=2}}</ref><ref name="kapoor">{{cite journal |pages=905–12 |doi=10.4065/mcp.2010.0159 |pmc=2947962 |title=Idiopathic Systemic Capillary Leak Syndrome (Clarkson's Disease): The Mayo Clinic Experience |year=2010 |last1=Kapoor |first1=Prashant |last2=Greipp |first2=Patricia T. |last3=Schaefer |first3=Eric W. |last4=Mandrekar |first4=Sumithra J. |last5=Kamal |first5=Arif H. |last6=Gonzalez-Paz |first6=Natalia C. |last7=Kumar |first7=Shaji |last8=Greipp |first8=Philip R. |journal=Mayo Clinic Proceedings |volume=85 |issue=10 |pmid=20634497}}</ref>


==Natural History==
==Natural History==

Revision as of 19:35, 28 January 2013

For patient information, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Capillary leak syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Capillary leak syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT Scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Surgery

Medical Therapy

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Capillary leak syndrome On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Capillary leak syndrome

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Capillary leak syndrome

CDC on Capillary leak syndrome

Capillary leak syndrome in the news

Blogs on Capillary leak syndrome

Directions to Hospitals Treating Capillary leak syndrome

Risk calculators and risk factors for Capillary leak syndrome

Synonyms and Keywords: Systemic capillary leak syndrome; SCLS; Clarkson's disease.



Natural History

The episode usually consists of two phases

1. The capillary leak phase (1-4 days) The initial phase is the capillary leak phase, lasting from 1 to 4 days. Clinical features are abdominal pain, nausea, generalized edema and hypotension that may result in cardiopulmonary collapse. Acute renal failure is due to acute tubular necrosis consequent to hypovolemia and rhabdomyolysis.

2. Recruitment of the interstitial fluid The second phase results in the recruitment of the initially extravasated fluid. Intravascular overload with polyuria and pulmonary edema often occur. Edema may be more severe due to massive fluid supply in the initial phase. It's necessary to monitor the patient in order to switch to depletion treatment with diuretics or hemofiltration.

Prognosis

Mortality is reported in 21% of the 57 cases described. However, better management of this condition has recently led to lower mortality.

In the Mayo Clinic’s experience, the median survival of 25 patients that were followed over 30 years (counting only SCLS-related deaths) was approximately 15 years, and their 5-year survival rate was 76%.[1][2] In European experience, the 5-year post-diagnosis survival rate was 85% in 23 patients who had received prophylactic treatment and 20% in 5 patients who had not.[3] However, better identification and management of this condition appears to be resulting in lower mortality and improving survival and quality-of-life results as of late.

Diagnosis

Symptoms

Generalized swelling may be present.

Physical Examination

Vitals

Skin

Generalized edema or anasarca

Laboratory Studies

External Links

References


Template:WS